|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1998-5-4
|
|
pubmed:abstractText |
Sustained-release ganciclovir implants are effective in delaying progression of newly diagnosed cytomegalovirus (CMV) retinitis. An uncontrolled case series was assembled to evaluate the efficacy of the intravitreal ganciclovir implant for patients with sight-threatening CMV retinitis who had previously failed to respond to intravenous ganciclovir and/or foscarnet.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0275-004X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
50-5
|
|
pubmed:dateRevised |
2006-12-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9502281-AIDS-Related Opportunistic Infections,
pubmed-meshheading:9502281-Adult,
pubmed-meshheading:9502281-Antiviral Agents,
pubmed-meshheading:9502281-Cytomegalovirus Retinitis,
pubmed-meshheading:9502281-Delayed-Action Preparations,
pubmed-meshheading:9502281-Drug Implants,
pubmed-meshheading:9502281-Female,
pubmed-meshheading:9502281-Follow-Up Studies,
pubmed-meshheading:9502281-Ganciclovir,
pubmed-meshheading:9502281-Humans,
pubmed-meshheading:9502281-Male,
pubmed-meshheading:9502281-Postoperative Complications,
pubmed-meshheading:9502281-Recurrence,
pubmed-meshheading:9502281-Retrospective Studies,
pubmed-meshheading:9502281-Treatment Outcome,
pubmed-meshheading:9502281-Visual Acuity
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Treatment of relapsed cytomegalovirus retinitis with the sustained-release ganciclovir implant.
|
|
pubmed:affiliation |
New England Eye Center, Boston, Massachusetts 02111, USA.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
